Hypertension

• FDA approval · 2009-10-22
  FDA Approved: RAMIPRIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

  The FDA approved a supplemental application for ramipril submitted by Hikma Pharmaceuticals USA Inc. The action confirms continued approval …

• FDA approval · 2009-10-16
  FDA Approved: MICARDIS — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)

  The FDA approves a supplemental application for Micardis (telmisartan) filed by Boehringer Ingelheim Pharmaceuticals, Inc.

• FDA approval · 2009-10-16
  FDA Approved: CHLOROTHIAZIDE — Original Application (Fresenius Kabi USA, LLC)

  FDA approves Fresenius Kabi USA, LLC's original abbreviated new drug application for chlorothiazide sodium, a thiazide diuretic. The product…

• FDA approval · 2009-09-17
  FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Glenmark Pharmaceuticals Inc., USA)

  FDA approved Glenmark's verapamil hydrochloride as an original generic application, adding a new generic calcium channel blocker to the mark…

• FDA approval · 2009-09-02
  FDA Approved: ATENOLOL — Supplemental Application (Aurobindo Pharma Limited)

  FDA approved a supplemental application for Atenolol from Aurobindo Pharma Limited, confirming approval of a generic Atenolol product under …

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2009-08-31
  FDA Approved: LISINOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

  FDA approved a supplemental application for a lisinopril and hydrochlorothiazide fixed-dose combination tablet from Lupin Pharmaceuticals, I…

• FDA approval · 2009-08-18
  FDA Approved: BISOPROLOL FUMARATE — Original Application (Unichem Pharmaceuticals (USA), Inc.)

  FDA approved a generic version of bisoprolol fumarate from Unichem Pharmaceuticals (USA), Inc. under an Original Application. It is indicate…

• FDA approval · 2009-07-23
  FDA Approved: BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)

  FDA approved a supplemental application for Benazepril hydrochloride from Amneal Pharmaceuticals of New York LLC, bringing a generic benazep…

• FDA approval · 2009-07-20
  FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)

  The FDA approved a supplemental application from Prasco Laboratories for the fixed-dose combination of amlodipine and atorvastatin (amlodipi…

• FDA approval · 2009-07-10
  FDA Approved: PRAZOSIN HYDROCHLORIDE — Supplemental Application (Prasco Laboratories)

  FDA approved a supplemental application for prazosin hydrochloride submitted by Prasco Laboratories.

• FDA approval · 2009-07-09
  FDA Approved: FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE — Original Application (Aurobindo Pharma Limited)

  FDA approved the original application for a generic combination tablet of fosinopril sodium and hydrochlorothiazide by Aurobindo Pharma Limi…

• FDA approval · 2009-07-09
  FDA Approved: FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE — Original Application (CIPLA USA INC.)

  FDA approved an original application for Fosinopril sodium and hydrochlorothiazide, a fixed-dose combination of an ACE inhibitor with a thia…

• FDA approval · 2009-06-12
  FDA Approved: HYZAAR — Supplemental Application (Organon LLC)

  FDA approved a supplemental application for HYZAAR, the fixed-dose combination of losartan potassium and hydrochlorothiazide, submitted by O…

• FDA approval · 2009-06-12
  FDA Approved: BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)

  FDA approved a supplemental application for benazepril hydrochloride from Aurobindo Pharma Limited, authorizing changes to the approved gene…

• FDA approval · 2009-06-10
  FDA Approved: DIURIL — Supplemental Application (Salix Pharmaceuticals, Inc)

  The FDA approved a supplemental application for DIURIL (chlorothiazide) submitted by Salix Pharmaceuticals.

• FDA approval · 2009-05-29
  FDA Approved: LISINOPRIL — Supplemental Application (Quallent Pharmaceuticals Health LLC)

  The FDA approved a supplemental application for lisinopril from Quallent Pharmaceuticals Health LLC, enabling continued access to lisinopril…

• FDA approval · 2009-05-29
  FDA Approved: HYDRALAZINE HYDROCHLORIDE — Original Application (Glenmark Pharmaceuticals Inc., USA)

  FDA approved hydralazine hydrochloride as an original application generic drug from Glenmark Pharmaceuticals for use in treating hypertensio…

• FDA approval · 2009-05-11
  FDA Approved: AZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)

  The FDA approved a supplemental application for AZOR, a fixed-dose combination of amlodipine besilate and olmesartan medoxomil, filed by Cos…

• FDA approval · 2009-05-04
  FDA Approved: FUROSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

  FDA approved a supplemental application for furosemide from Hikma Pharmaceuticals USA Inc., updating the labeling on an existing product.

• FDA approval · 2009-05-04
  FDA Approved: FUROSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

  The FDA approved a supplemental application for furosemide submitted by Hikma Pharmaceuticals USA Inc.

• FDA approval · 2009-05-04
  FDA Approved: FUROSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

  The FDA approved a supplemental application for furosemide submitted by Hikma Pharmaceuticals USA Inc.

• FDA approval · 2009-05-04
  FDA Approved: AMLODIPINE BESYLATE — Original Application (Ascend Laboratories, LLC)

  FDA approved Ascend Laboratories, LLC's original application for amlodipine besylate, a generic version, for indications including hypertens…

• FDA approval · 2009-04-30
  FDA Approved: EXFORGE HCT — Original Application (Novartis Pharmaceuticals Corporation)

  FDA approved EXFORGE HCT, a fixed-dose combination of amlodipine, valsartan, and hydrochlorothiazide, through an original application for th…

• FDA approval · 2009-04-30
  FDA Approved: SPIRONOLACTONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

  FDA approved Sun Pharmaceutical Industries, Inc.'s supplemental ANDA for spironolactone, granting approval of their generic product for the …

• FDA approval · 2009-04-29
  FDA Approved: TRIAMTERENE AND HYDROCHLOROTHIAZIDE — Supplemental Application (BluePoint Laboratories)

  FDA approved a supplemental application for Triamterene and Hydrochlorothiazide submitted by BluePoint Laboratories. The product is a generi…